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The Surviving Sepsis Campaign panel recently recom-
mended that “mechanically ventilated patients with 
COVID-19 should be managed similarly to other patients 
with acute respiratory failure in the ICU [1].”
Yet, COVID-19 pneumonia [2], despite falling in most 
of the circumstances under the Berlin definition of ARDS 
[3], is a specific disease, whose distinctive features are 
severe hypoxemia often associated with near normal res-
piratory system compliance (more than 50% of the 150 
patients measured by the authors and further confirmed 
by several colleagues in Northern Italy). This remarkable 
combination is almost never seen in severe ARDS. These 
severely hypoxemic patients despite sharing a single eti-
ology (SARS-CoV-2) may present quite differently from 
one another: normally breathing (“silent” hypoxemia) 
or remarkably dyspneic; quite responsive to nitric oxide 
or not; deeply hypocapnic or normo/hypercapnic; and 
either responsive to prone position or not. Therefore, 
the same disease actually presents itself with impressive 
non-uniformity.
Based on detailed observation of several cases and 
discussions with colleagues treating these patients, we 
hypothesize that the different COVID-19 patterns found 
at presentation in the emergency department depend on 
the interaction between three factors: (1) the severity of 
the infection, the host response, physiological reserve and 
comorbidities; (2) the ventilatory responsiveness of the 
patient to hypoxemia; (3) the time elapsed between the 
onset of the disease and the observation in the hospital. 
The interaction between these factors leads to the devel-
opment of a time-related disease spectrum within two 
primary “phenotypes”: Type L, characterized by Low 
elastance (i.e., high compliance), Low ventilation-to-per-
fusion ratio, Low lung weight and Low recruitability and 
Type H, characterized by High elastance, High right-to-
left shunt, High lung weight and High recruitability.
COVID‑19 pneumonia, Type L
At the beginning, COVID-19 pneumonia presents with 
the following characteristics:
  • Low elastance. The nearly normal compliance indi-
cates that the amount of gas in the lung is nearly nor-
mal [4].
  • Low ventilation-to-perfusion (VA/Q) ratio. Since the 
gas volume is nearly normal, hypoxemia may be best 
explained by the loss of regulation of perfusion and 
by loss of hypoxic vasoconstriction. Accordingly, at 
this stage, the pulmonary artery pressure should be 
near normal.
  • Low lung weight. Only ground-glass densities are pre-
sent on CT scan, primarily located subpleurally and 
along the lung fissures. Consequently, lung weight is 
only moderately increased.
  • Low lung recruitability. The amount of non-aerated 
tissue is very low; consequently, the recruitability is 
low [5].
To conceptualize these phenomena, we hypothesize 
the following sequence of events: the viral infection leads 
to a modest local subpleural interstitial edema (ground-
glass lesions) particularly located at the interfaces 
between lung structures with different elastic properties, 
where stress and strain are concentrated [6]. Vasoplegia 
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accounts for severe hypoxemia. The normal response 
to hypoxemia is to increase minute ventilation, primar-
ily by increasing the tidal volume [7] (up to 15–20  ml/
kg), which is associated with a more negative intratho-
racic inspiratory pressure. Undetermined factors other 
than hypoxemia markedly stimulate, in these patients, 
the respiratory drive. The near normal compliance, how-
ever, explains why some of the patients present without 
dyspnea as the patient inhales the volume he expects. 
This increase in minute ventilation leads to a decrease in 
 PaCO2.
The evolution of the disease: transitioning 
between phenotypes
The Type L patients may remain unchanging for a period 
and then improve or worsen. The possible key feature 
which determines the evolution of the disease, other than 
the severity of the disease itself, is the depth of the nega-
tive intrathoracic pressure associated with the increased 
tidal volume in spontaneous breathing. Indeed, the com-
bination of a negative inspiratory intrathoracic pressure 
and increased lung permeability due to inflammation 
results in interstitial lung edema. This phenomenon, 
initially described by Barach in [8] and Mascheroni in 
[9] both in an experimental setting, has been recently 
recognized as the leading cause of patient self-inflicted 
lung injury (P-SILI) [10]. Over time, the increased 
edema increases lung weight, superimposed pressure 
and dependent atelectasis. When lung edema reaches a 
certain magnitude, the gas volume in the lung decreases, 
and the tidal volumes generated for a given inspiratory 
pressure decrease [11]. At this stage, dyspnea develops, 
which in turn leads to worsening P-SILI. The transition 
from Type L to Type H may be due to the evolution of 
the COVID-19 pneumonia on one hand and the injury 
attributable to high-stress ventilation on the other.
COVID‑19 pneumonia, Type H
The Type H patient:
  • High elastance. The decrease in gas volume due to 
increased edema accounts for the increased lung 
elastance.
  • High right-to-left shunt. This is due to the fraction 
of cardiac output perfusing the non-aerated tissue 
which develops in the dependent lung regions due to 
the increased edema and superimposed pressure.
  • High lung weight. Quantitative analysis of the CT 
scan shows a remarkable increase in lung weight 
(> 1.5 kg), on the order of magnitude of severe ARDS 
[12].
  • High lung recruitability. The increased amount of 
non-aerated tissue is associated, as in severe ARDS, 
with increased recruitability [5].
The Type H pattern, 20–30% of patients in our series, 
fully fits the severe ARDS criteria: hypoxemia, bilateral 
infiltrates, decreased the respiratory system compliance, 
increased lung weight and potential for recruitment.
Figure 1 summarizes the time course we described. In 
panel a, we show the CT in spontaneous breathing of a 
Type L patient at admission, and in panel b, its transition 
in Type H after 7 days of noninvasive support. As shown, 
a similar degree of hypoxemia was associated with differ-
ent patterns in lung imaging.
Respiratory treatment
Given this conceptual model, it follows that the respira-
tory treatment offered to Type L and Type H patients 
must be different. The proposed treatment is consistent 
with what observed in COVID-19, even though the over-
whelming number of patients seen in this pandemic may 
limit its wide applicability.
1. The first step to reverse hypoxemia is through an 
increase in  FiO2 to which the Type L patient responds 
well, particularly if not yet breathless.
2. In Type L patients with dyspnea, several noninva-
sive options are available: high-flow nasal cannula 
(HFNC), continuous positive airway pressure (CPAP) 
or noninvasive ventilation (NIV). At this stage, the 
measurement (or the estimation) of the inspiratory 
esophageal pressure swings is crucial [13]. In the 
absence of the esophageal manometry, surrogate 
measures of work of breathing, such as the swings 
of central venous pressure [14] or clinical detection 
of excessive inspiratory effort, should be assessed. In 
intubated patients, the P0.1 and Pocclusion should also 
be determined. High PEEP, in some patients, may 
decrease the pleural pressure swings and stop the 
vicious cycle that exacerbates lung injury. However, 
high PEEP in patients with normal compliance may 
have detrimental effects on hemodynamics. In any 
case, noninvasive options are questionable, as they 
may be associated with high failure rates and delayed 
intubation, in a disease which typically lasts several 
weeks.
3. The magnitude of inspiratory pleural pressures 
swings may determine the transition from the Type 
L to the Type H phenotype. As esophageal pressure 
swings increase from 5 to 10  cmH2O—which are 
generally well tolerated—to above 15  cmH2O, the 
risk of lung injury increases and therefore intubation 
should be performed as soon as possible.
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4. Once intubated and deeply sedated, the Type L 
patients, if hypercapnic, can be ventilated with vol-
umes greater than 6 ml/kg (up to 8–9 ml/kg), as the 
high compliance results in tolerable strain without 
the risk of VILI. Prone positioning should be used 
only as a rescue maneuver, as the lung conditions are 
“too good” for the prone position effectiveness, which 
is based on improved stress and strain redistribution. 
The PEEP should be reduced to 8–10  cmH2O, given 
that the recruitability is low and the risk of hemo-
dynamic failure increases at higher levels. An early 
intubation may avert the transition to Type H pheno-
type.
5. Type H patients should be treated as severe ARDS, 
including higher PEEP, if compatible with hemody-
namics, prone positioning and extracorporeal sup-
port.
In conclusion, Type L and Type H patients are best 
identified by CT scan and are affected by different patho-
physiological mechanisms. If not available, signs which 
are implicit in Type L and Type H definition could be 
used as surrogates: respiratory system elastance and 
recruitability. Understanding the correct pathophysiol-
ogy is crucial to establishing the basis for appropriate 
treatment.
Fig. 1 a CT scan acquired during spontaneous breathing. The cumulative distribution of the CT number is shifted to the left (well‑aerated compart‑
ments), being the 0 to − 100 HU compartment, the non‑aerated tissue virtually 0. Indeed, the total lung tissue weight was 1108 g, 7.8% of which 
was not aerated and the gas volume was 4228 ml. Patient receiving oxygen with venturi mask inspired oxygen fraction of 0.8. b CT acquired during 
mechanical ventilation at end‑expiratory pressure at 5  cmH2O of PEEP. The cumulative distribution of the CT scan is shifted to the right (non‑aerated 
compartments), while the left compartments are greatly reduced. Indeed, the total lung tissue weight was 2744 g, 54% of which was not aerated 
and the gas volume was 1360 ml. The patient was ventilated in volume controlled mode, 7.8 ml/kg of tidal volume, respiratory rate of 20 breaths 
per minute, inspired oxygen fraction of 0.7
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